- Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
-
Han AR, Kim K, Jang JH, Kim WS, Ahn JS, Jung CW, Lee MH, Kang WK
- KMID: 1713461
- J Korean Med Sci.
- 2008 Apr;23(2):278-283.
- doi: 10.3346/jkms.2008.23.2.278
We analyzed the efficacy and toxicity of a modified Cancer and Leukemia Group B (CALGB) 19802 regimen in adult acute lymphoblastic leukemia (ALL). From February 2002 to August 2005, 25... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
-
Yoon JH, Park JA, Kim EK, Kang HJ, Shin HY, Ahn HS
- KMID: 1779131
- J Korean Med Sci.
- 2009 Apr;24(2):281-288.
- doi: 10.3346/jkms.2009.24.2.281
Relapse is the major cause of treatment failure in acute lymphoblastic leukemia (ALL), yet there is no established treatment for relapsed ALL. To improve the induction remission rate, we modified... -
- CITED
-
- Close
- SHARE
-
- Close
- Irreversible Paraplegia Following One Time Prophylactic Intrathecal Chemotherapy in an Adult Patient with Acute Lymphoblastic Leukemia
-
Lee HY, Im SI, Kang MH, Kim KM, Kim SH, Kim HG, Kang JH, Lee GW
- KMID: 2396099
- Yonsei Med J.
- 2008 Feb;49(1):151-154.
We present an adult female patient who developed irreversible paraplegia and areflexia four days post intrathecal chemotherapy with methotrexate, cytosine arabinoside and hydrocortisone. On magnetic resonance imaging (MRI) of the... -
- CITED
-
- Close
- SHARE
-
- Close
